Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hereditary considerations in common disorders.

C E Anderson, J I Rotter, J Zonana

    Pediatric Clinics of North America
    |August 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Genome-wide analysis of mitochondrial DNA copy number reveals loci implicated in nucleotide metabolism, platelet activation, and megakaryocyte proliferation.

    Human genetics·2021
    Same author

    Breaking free from thermodynamic constraints: thermal acclimation and metabolic compensation in a freshwater zooplankton species.

    The Journal of experimental biology·2020
    Same author

    Genome-wide meta-analysis of variant-by-diuretic interactions as modulators of lipid traits in persons of European and African ancestry.

    The pharmacogenomics journal·2019
    Same author

    Bidirectional Mendelian randomization to explore the causal relationships between body mass index and polycystic ovary syndrome.

    Human reproduction (Oxford, England)·2018
    Same author

    Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiology.

    The pharmacogenomics journal·2017
    Same author

    Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.

    The pharmacogenomics journal·2016
    Same journal

    Barriers, Breakthroughs, and the Future of Pediatric Dermatologic Care.

    Pediatric clinics of North America·2026
    Same journal

    Advancing Pediatric Dermatology: Innovations in Care and Access.

    Pediatric clinics of North America·2026
    Same journal

    No Child Left Behind: Advancing Access in Pediatric Dermatology, a 4-Year, Single-Center Experience.

    Pediatric clinics of North America·2026
    Same journal

    Telemedicine and Access to Pediatric Dermatology Care.

    Pediatric clinics of North America·2026
    Same journal

    Inequitable Reimbursement for Pediatric Providers: A Review of Structural Factors that Disincentivize the Care of Children.

    Pediatric clinics of North America·2026
    Same journal

    Medical Photography's Power to Change Medical Care.

    Pediatric clinics of North America·2026
    See all related articles

    Clinical geneticists face challenges in determining exact recurrence risks for common diseases due to genetic heterogeneity. Current approaches rely on empirical data, necessitating ongoing updates in genetic counseling as knowledge evolves.

    Area of Science:

    • Medical Genetics
    • Clinical Genetics
    • Genetics of Common Diseases

    Background:

    • Clinical geneticists encounter complexities in diagnosing and managing common diseases with genetic components.
    • Genetic heterogeneity, where different genetic factors cause similar disorders, complicates risk assessment.

    Purpose of the Study:

    • To review the current clinical geneticist's approach to the genetics of common diseases.
    • To highlight the significance of genetic heterogeneity in understanding these disorders.
    • To address the limitations in providing precise recurrence risks for families.

    Main Methods:

    • Review of current clinical genetics practices.
    • Emphasis on the concept of genetic heterogeneity.
    • Analysis of available risk data and counseling strategies.

    Related Experiment Videos

    Main Results:

    • Exact recurrence risks are often not feasible for most families with common genetic disorders.
    • Empirical risk data, though imprecise, is currently utilized to provide an estimate of risk magnitude, which is often low.
    • Genetic heterogeneity is a crucial factor that must be recognized and further investigated.

    Conclusions:

    • Physicians must acknowledge the current inability to provide exact recurrence risks for common diseases.
    • Genetic counseling requires continuous updates as scientific understanding improves.
    • Further research into genetic heterogeneity is essential for developing improved risk assessment and management strategies.